Email updates

Keep up to date with the latest news and content from Molecular Neurodegeneration and BioMed Central.

Open Access Highly Accessed Research article

Regulation of mitochondrial permeability transition pore by PINK1

Clement A Gautier14, Emilie Giaime1, Erica Caballero2, Lucía Núñez2, Zhiyin Song3, David Chan3, Carlos Villalobos2 and Jie Shen1*

Author Affiliations

1 Center for Neurologic Diseases, Department of Neurology, Brigham & Women’s Hospital, Program in Neuroscience, Harvard Medical School, Boston, MA, 02115, USA

2 Instituto de Biología y Genética Molecular, Universidad de Valladolid and Consejo Superior de Investigaciones Científicas, Valladolid, Spain

3 Division of Biology and Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA, 91125, USA

4 Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975, Paris, 75013, France

For all author emails, please log on.

Molecular Neurodegeneration 2012, 7:22  doi:10.1186/1750-1326-7-22

Published: 25 May 2012

Abstract

Background

Loss-of-function mutations in PTEN-induced kinase 1 (PINK1) have been linked to familial Parkinson’s disease, but the underlying pathogenic mechanism remains unclear. We previously reported that loss of PINK1 impairs mitochondrial respiratory activity in mouse brains.

Results

In this study, we investigate how loss of PINK1 impairs mitochondrial respiration using cultured primary fibroblasts and neurons. We found that intact mitochondria in PINK1−/− cells recapitulate the respiratory defect in isolated mitochondria from PINK1−/− mouse brains, suggesting that these PINK1−/− cells are a valid experimental system to study the underlying mechanisms. Enzymatic activities of the electron transport system complexes are normal in PINK1−/− cells, but mitochondrial transmembrane potential is reduced. Interestingly, the opening of the mitochondrial permeability transition pore (mPTP) is increased in PINK1−/− cells, and this genotypic difference between PINK1−/− and control cells is eliminated by agonists or inhibitors of the mPTP. Furthermore, inhibition of mPTP opening rescues the defects in transmembrane potential and respiration in PINK1−/− cells. Consistent with our earlier findings in mouse brains, mitochondrial morphology is similar between PINK1−/− and wild-type cells, indicating that the observed mitochondrial functional defects are not due to morphological changes. Following FCCP treatment, calcium increases in the cytosol are higher in PINK1−/− compared to wild-type cells, suggesting that intra-mitochondrial calcium concentration is higher in the absence of PINK1.

Conclusions

Our findings show that loss of PINK1 causes selective increases in mPTP opening and mitochondrial calcium, and that the excessive mPTP opening may underlie the mitochondrial functional defects observed in PINK1−/− cells.

Keywords:
Parkinson’s disease; Mitochondrial respiration; Mitochondrial transmembrane potential; Mitochondrial permeability transition pore; Calcium